UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:CFD-EIF3B |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: CFD-EIF3B | FusionPDB ID: 16087 | FusionGDB2.0 ID: 16087 | Hgene | Tgene | Gene symbol | CFD | EIF3B | Gene ID | 200576 | 8662 |
Gene name | phosphoinositide kinase, FYVE-type zinc finger containing | eukaryotic translation initiation factor 3 subunit B | |
Synonyms | CFD|FAB1|HEL37|PIP5K|PIP5K3|ZFYVE29 | EIF3-ETA|EIF3-P110|EIF3-P116|EIF3S9|PRT1 | |
Cytomap | 2q34 | 7p22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | 1-phosphatidylinositol 3-phosphate 5-kinasePIPkin-IIIepididymis luminal protein 37phosphatidylinositol 3-phosphate 5-kinase type IIIphosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, type IIIphosphoinositide kinase, FYVE finger containin | eukaryotic translation initiation factor 3 subunit Beukaryotic translation initiation factor 3 subunit 9eukaryotic translation initiation factor 3, subunit 9 (eta, 116kD)eukaryotic translation initiation factor 3, subunit 9 eta, 116kDaprt1 homolog | |
Modification date | 20200327 | 20200322 | |
UniProtAcc | Q9UEE9 | P55884 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000327726, ENST00000592860, | ENST00000360876, ENST00000397011, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 3 X 1 X 3=9 | 16 X 22 X 8=2816 |
# samples | 4 | 22 | |
** MAII score | log2(4/9*10)=2.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(22/2816*10)=-3.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: CFD [Title/Abstract] AND EIF3B [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CFD(861956)-EIF3B(2411411), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | CFD-EIF3B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CFD-EIF3B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | EIF3B | GO:0006413 | translational initiation | 8995410|17581632 |
Tgene | EIF3B | GO:0006446 | regulation of translational initiation | 8995410 |
Tgene | EIF3B | GO:0075522 | IRES-dependent viral translational initiation | 9573242 |
Tgene | EIF3B | GO:0075525 | viral translational termination-reinitiation | 21347434 |
Fusion gene breakpoints across CFD (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across EIF3B (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ESCA | TCGA-L5-A88W | CFD | chr19 | 861956 | + | EIF3B | chr7 | 2411411 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000327726 | CFD | chr19 | 861956 | + | ENST00000360876 | EIF3B | chr7 | 2411411 | + | 2237 | 852 | 135 | 1682 | 515 |
ENST00000327726 | CFD | chr19 | 861956 | + | ENST00000397011 | EIF3B | chr7 | 2411411 | + | 2164 | 852 | 135 | 1682 | 515 |
ENST00000592860 | CFD | chr19 | 861956 | + | ENST00000360876 | EIF3B | chr7 | 2411411 | + | 2021 | 636 | 0 | 1466 | 488 |
ENST00000592860 | CFD | chr19 | 861956 | + | ENST00000397011 | EIF3B | chr7 | 2411411 | + | 1948 | 636 | 0 | 1466 | 488 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000327726 | ENST00000360876 | CFD | chr19 | 861956 | + | EIF3B | chr7 | 2411411 | + | 0.002455885 | 0.9975441 |
ENST00000327726 | ENST00000397011 | CFD | chr19 | 861956 | + | EIF3B | chr7 | 2411411 | + | 0.002597558 | 0.99740237 |
ENST00000592860 | ENST00000360876 | CFD | chr19 | 861956 | + | EIF3B | chr7 | 2411411 | + | 0.004099581 | 0.99590045 |
ENST00000592860 | ENST00000397011 | CFD | chr19 | 861956 | + | EIF3B | chr7 | 2411411 | + | 0.004274832 | 0.99572515 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >16087_16087_1_CFD-EIF3B_CFD_chr19_861956_ENST00000327726_EIF3B_chr7_2411411_ENST00000360876_length(amino acids)=515AA_BP=239 MGRCPPGERPAPSTLIKAPPGPCLGQCLSHSGFTMHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLV AEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGT LCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGVVTNFEIFRMREKQVPVDVVEMKETIIAFA WEPNGSKFAVLHGEAPRISVSFYHVKNNGKIELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEW DPTGRYVVTSVSWWSHKVDNAYWLWTFQGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQIKKDLKKYSKIFEQKDRLSQSKASKELVER -------------------------------------------------------------- >16087_16087_2_CFD-EIF3B_CFD_chr19_861956_ENST00000327726_EIF3B_chr7_2411411_ENST00000397011_length(amino acids)=515AA_BP=239 MGRCPPGERPAPSTLIKAPPGPCLGQCLSHSGFTMHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLV AEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGT LCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGVVTNFEIFRMREKQVPVDVVEMKETIIAFA WEPNGSKFAVLHGEAPRISVSFYHVKNNGKIELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEW DPTGRYVVTSVSWWSHKVDNAYWLWTFQGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQIKKDLKKYSKIFEQKDRLSQSKASKELVER -------------------------------------------------------------- >16087_16087_3_CFD-EIF3B_CFD_chr19_861956_ENST00000592860_EIF3B_chr7_2411411_ENST00000360876_length(amino acids)=488AA_BP=212 MHSWERLAVLVLLGAAACGEEAWAWAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAH SLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPV LDRATCNRRTHHDGAITERLMCAESNRRDSCKGVVTNFEIFRMREKQVPVDVVEMKETIIAFAWEPNGSKFAVLHGEAPRISVSFYHVKN NGKIELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEWDPTGRYVVTSVSWWSHKVDNAYWLWTF QGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQIKKDLKKYSKIFEQKDRLSQSKASKELVERRRTMMEDFRKYRKMAQELYMEQKNERL -------------------------------------------------------------- >16087_16087_4_CFD-EIF3B_CFD_chr19_861956_ENST00000592860_EIF3B_chr7_2411411_ENST00000397011_length(amino acids)=488AA_BP=212 MHSWERLAVLVLLGAAACGEEAWAWAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAH SLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPV LDRATCNRRTHHDGAITERLMCAESNRRDSCKGVVTNFEIFRMREKQVPVDVVEMKETIIAFAWEPNGSKFAVLHGEAPRISVSFYHVKN NGKIELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEWDPTGRYVVTSVSWWSHKVDNAYWLWTF QGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQIKKDLKKYSKIFEQKDRLSQSKASKELVERRRTMMEDFRKYRKMAQELYMEQKNERL -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:861956/chr7:2411411) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CFD | EIF3B |
FUNCTION: May play a role during embryogenesis. {ECO:0000250}. | FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:9388245, PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:9388245, PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03001, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815, ECO:0000269|PubMed:9388245}.; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 554_598 | 538.0 | 810.0 | Repeat | Note=WD 6 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 599_642 | 538.0 | 810.0 | Repeat | Note=WD 7 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 643_685 | 538.0 | 810.0 | Repeat | Note=WD 8 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 554_598 | 538.0 | 791.0 | Repeat | Note=WD 6 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 599_642 | 538.0 | 791.0 | Repeat | Note=WD 7 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 643_685 | 538.0 | 791.0 | Repeat | Note=WD 8 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CFD | chr19:861956 | chr7:2411411 | ENST00000327726 | + | 4 | 5 | 26_253 | 205.0 | 254.0 | Domain | Peptidase S1 |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 185_268 | 538.0 | 810.0 | Domain | RRM | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 185_268 | 538.0 | 791.0 | Domain | RRM | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 285_324 | 538.0 | 810.0 | Repeat | Note=WD 1 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 325_365 | 538.0 | 810.0 | Repeat | Note=WD 2 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 366_425 | 538.0 | 810.0 | Repeat | Note=WD 3 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 426_489 | 538.0 | 810.0 | Repeat | Note=WD 4 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000360876 | 9 | 19 | 490_553 | 538.0 | 810.0 | Repeat | Note=WD 5 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 285_324 | 538.0 | 791.0 | Repeat | Note=WD 1 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 325_365 | 538.0 | 791.0 | Repeat | Note=WD 2 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 366_425 | 538.0 | 791.0 | Repeat | Note=WD 3 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 426_489 | 538.0 | 791.0 | Repeat | Note=WD 4 | |
Tgene | EIF3B | chr19:861956 | chr7:2411411 | ENST00000397011 | 9 | 19 | 490_553 | 538.0 | 791.0 | Repeat | Note=WD 5 |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
CFD | |
EIF3B |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to CFD-EIF3B |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to CFD-EIF3B |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |